No definition available.
Disorders related to short gestation and low birth weight, not elsewhere classified
EFO MESH Endpoint Browser PheWeb
P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
846 |
4. Check minimum number of eventsNone |
846 |
5. Include endpointsNone |
846 |
6. Filter based on genotype QC (FinnGen only) |
846 |
Control definitions (FinnGen only)
- Control exclude
- P16_DISORD_RELATED_LENGTH_GESTATION_FETAL_GROWTH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P0[5-8]
- Name in latin
- Perturbationes ad gestationem brevem et pondus partuale leve pertinentes non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Disorders related to short gestation and low birth weight, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Disorders related to length of gestation and fetal growth
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 51969 | 23864 | 28104 |
| Only index persons | 27383 | 12581 | 14802 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.74 | 0.68 | 0.79 |
| Only index persons | 0.52 | 0.46 | 0.57 |
| Median age at first event (years) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 846 | 487 | 359 |
| Unadjusted period prevalence (%) | 0.16 | 0.17 | 0.16 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 729
- Matched controls
- 7068
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P07.3
ICD-10 Finland
Other preterm infants
+∞
323.0
587
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
38.7
238.9
312
134
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
+∞
140.9
132
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
159.1
139.3
145
11
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
583.9
106.4
104
*
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
+∞
88.4
84
*
P05.1
ICD-10 Finland
Small for gestational age
+∞
87.3
83
*
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
120.8
72.5
78
7
P07.1
ICD-10 Finland
Other low birth weight
+∞
69.1
66
*
P07.2
ICD-10 Finland
Extreme immaturity
+∞
64.9
62
*
602
Kela drug reimbursment
Children's severe malnutrition
10.3
60.4
126
141
P05.0
ICD-10 Finland
Light for gestational age
+∞
50.0
48
*
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
180.6
50.0
52
*
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
11.0
44.0
87
86
WX722
NOMESCO Finland
PEEP
11.0
40.7
80
78
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
+∞
40.5
39
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
6.6
40.3
111
188
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
32.5
40.1
53
17
H35.1
ICD-10 Finland
Retinopathy of prematurity
+∞
32.2
31
*
Z38.3
ICD-10 Finland
Twin, born in hospital
86.4
30.6
34
*
P29.30
ICD-10 Finland
Delayed closure of the ductus arteriosus
52.3
30.2
36
7
R4110
NOMESCO Finland
Physiotherapy
2.7
25.9
226
1021
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
+∞
21.7
21
*
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
6.2
21.7
60
101
P70.1
ICD-10 Finland
Syndrome of infant of a diabetic mother
16.4
21.2
34
21
WX882
NOMESCO Finland
High dependency care
3.0
20.8
130
470
Z3229
NOMESCO Finland
Other healthcare associate professional
3.1
20.3
126
452
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
14.5
19.7
33
23
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.6
19.5
166
722
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
19.3
180
826
J45.1
ICD-10 Finland
Nonallergic asthma
2.9
19.2
131
498
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
5.7
18.9
55
99
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
+∞
17.6
17
*
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
36.6
17.4
22
6
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
17.1
123
482
WX730
NOMESCO Finland
Conventional respirator
10.4
17.0
33
32
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.3
16.9
65
159
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
16.6
281
1669
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
+∞
16.5
16
*
P07.0
ICD-10 Finland
Extremely low birth weight
+∞
16.5
16
*
Z3226
NOMESCO Finland
Physiotherapist
2.2
16.4
209
1102
E34.31
ICD-10 Finland
Short stature, prenatal disorder
9.5
16.2
33
35
Z2446
NOMESCO Finland
Social worker
2.3
16.1
175
856
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
10.1
15.7
31
31
P08.1
ICD-10 Finland
Other heavy for gestational age infants
+∞
15.5
15
*
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
7.7
15.2
35
46
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
4.4
15.0
55
128
RK520
NOMESCO Finland
NA
28.4
15.0
20
7
A11JC
ATC
Vitamins, other combinations
28.4
15.0
20
7
RK312
NOMESCO Finland
NA
13.0
15.0
26
20
XG413
NOMESCO Finland
Spirometry with oscillometry
4.7
14.4
49
106
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
14.1
223
1275
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
13.3
132
613
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
13.3
241
1444
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
12.7
88
335
P22.8
ICD-10 Finland
Other respiratory distress of newborn
10.4
12.6
24
23
R62.0
ICD-10 Finland
Delayed milestone
2.9
12.4
79
286
ZXE00
NOMESCO Finland
One hour or less
1.8
12.2
293
1921
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
12.0
201
1162
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
11.7
166
899
Z2221
NOMESCO Finland
Medical doctor
1.9
11.7
197
1138
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
16.2
11.5
18
11
6BB16
NOMESCO Finland
NA
29.6
11.5
15
5
WX732
NOMESCO Finland
High frequency respirator
118.2
11.3
12
*
Z3231
NOMESCO Finland
Registered nurse
1.7
10.9
283
1883
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
10.5
197
1180
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
2.4
10.2
86
366
K40.2
ICD-10 Finland
Bilateral inguinal hernia, without obstruction or gangrene
15.8
10.2
16
10
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
10.5
10.1
19
18
RS220
NOMESCO Finland
NA
4.4
9.9
35
80
R03BA02
ATC
budesonide; inhalant
2.0
9.6
127
663
P52.0
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newborn
54.1
9.5
11
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
9.4
270
1832
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
9.3
139
763
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
9.2
126
669
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
9.1
133
725
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
6.6
9.0
22
33
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
9.0
155
894
Z94.0
ICD-10 Finland
Kidney transplant status
5.3
8.9
26
49
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
8.7
181
1111
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.3
8.6
17
18
ZXD05
NOMESCO Finland
Urgent procedure
1.8
8.6
157
921
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
4.3
8.6
31
73
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
49.1
8.6
10
*
RK410
NOMESCO Finland
NA
49.1
8.6
10
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.7
8.5
28
60
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.7
8.5
55
204
XA800
NOMESCO Finland
Neuropsychological investigation
2.2
8.4
84
388
137
Kela drug reimbursment
Uraemia requiring dialysis
6.8
8.4
20
29
P28.4
ICD-10 Finland
Other apnoea of newborn
27.0
8.4
11
*
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
+∞
8.2
8
*
P61.2
ICD-10 Finland
Anaemia of prematurity
+∞
8.2
8
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.8
8.1
22
38
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
8.1
75
336
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.1
85
405
RT150
NOMESCO Finland
NA
4.0
8.1
31
78
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.9
8.0
25
51
P03.4
ICD-10 Finland
Fetus and newborn affected by caesarean delivery
11.5
7.9
14
12
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
8.8
7.9
16
18
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
7.9
60
243
H66.9
ICD-10 Finland
Otitis media, unspecified
1.7
7.8
211
1391
A03FA02
ATC
cisapride; oral, rectal
3.2
7.8
39
122
R03AC02
ATC
salbutamol; inhalant
1.6
7.7
374
2857
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.9
7.7
30
77
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
9.3
7.6
15
16
WX704
NOMESCO Finland
Intubation
2.8
7.6
46
164
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.1
7.5
89
443
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
7.5
78
366
P02.1
ICD-10 Finland
Fetus and newborn affected by other forms of placental separation and haemorrhage
18.0
7.5
11
6
RK310
NOMESCO Finland
NA
8.7
7.4
15
17
WW500
NOMESCO Finland
Blood transfusion
3.2
7.4
37
116
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
7.4
78
372
XKC03
NOMESCO Finland
Water cystometry
6.1
7.4
19
31
ZX114
NOMESCO Finland
Intramuscular
4.0
7.4
28
70
WX725
NOMESCO Finland
Noninvasive ventilation
4.2
7.3
26
61
P77
ICD-10 Finland
Necrotizing enterocolitis of fetus and newborn
78.4
7.3
8
*
ZXA10
NOMESCO Finland
Bilateral
1.8
7.3
127
732
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
7.3
143
858
UDC00
NOMESCO Finland
Ear microscopy
2.1
7.2
77
369
A11CC03
ATC
alfacalcidol; systemic
4.0
7.1
27
68
KAC00
NOMESCO Finland
Nephrectomy
6.1
7.1
18
29
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.2
7.1
75
356
TJF80
NOMESCO Finland
Ostomy education
5.4
7.1
20
37
H50.31
ICD-10 Finland
Intermittent exotropia
3.3
7.1
34
104
7AA02
NOMESCO Finland
NA
29.4
7.1
9
*
P00.8
ICD-10 Finland
Fetus and newborn affected by other maternal conditions
19.6
7.0
10
5
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.9
171
1097
C08CA01
ATC
amlodipine; oral
3.4
6.9
31
90
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.4
6.8
59
254
RL140
NOMESCO Finland
NA
3.7
6.7
27
72
JF2AB
NOMESCO Finland
Colongraphy with X-ray
16.4
6.6
10
6
P59.9
ICD-10 Finland
Neonatal jaundice, unspecified
2.8
6.6
40
144
Z99.2
ICD-10 Finland
Dependence on renal dialysis
7.0
6.6
15
21
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
7.0
6.6
15
21
EMB30
NOMESCO Finland
Adenotomy
1.7
6.5
157
996
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
6.5
109
622
B03XA02
ATC
darbepoetin alfa; parenteral
12.0
6.5
11
9
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.8
6.4
38
134
P29.31
ICD-10 Finland
Persistent fetal circulation
9.8
6.4
12
12
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
6.4
92
494
H01AC01
ATC
somatropin; parenteral
2.8
6.4
38
135
R03BA05
ATC
fluticasone; inhalant
1.6
6.4
181
1204
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
6.4
111
639
B03XA01
ATC
erythropoietin; parenteral
6.1
6.3
16
26
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
5.2
6.3
18
34
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.6
6.3
17
30
P01.11
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes more than 7 days before delivery
+∞
6.2
6
*
A12AA04
ATC
calcium carbonate; oral
5.1
6.2
18
35
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.1
6.1
22
53
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
6.1
52
223
FM2CE
NOMESCO Finland
NA
2.0
6.1
75
382
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.7
6.1
39
144
127
Kela drug reimbursment
Transplant complication
3.3
6.1
28
84
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
6.0
70
346
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
6.2
6.0
15
24
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
3.9
6.0
23
59
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
6.0
91
500
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
52
5.17
12.92
8.3
8.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
28
61
4.57
11.64
7.5
6.7
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
28
61
4.57
11.64
7.1
6.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
69
3.89
9.18
11.9
9.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
125
737
1.76
7.17
5.1
3.3
%
21.7
21.8
0.04
119
700
(40768446) Kidney Pathology biopsy report
26
78
3.30
7.04
3.0
2.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
199
1337
1.58
6.88
16.9
11.4
mmol/l
1.4
1.3
2.32
193
1279
(3044640) Blood type and Crossmatch panel - Blood
212
1448
1.56
6.82
3.5
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
186
1237
1.59
6.70
3.3
3.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
37
140
2.63
6.70
4.9
4.4
umol/l
24.3
24.0
0.05
37
140
(3004789) Transferrin [Mass/volume] in Serum or Plasma
129
791
1.69
6.41
4.9
3.1
g/l
2.6
2.6
0.34
124
755
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
207
1425
1.54
6.38
22.3
9.6
mmol/l
0.9
0.9
0.04
152
1022
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
207
1429
1.54
6.29
22.5
9.6
kpa
5.1
5.0
2.44
201
1380
(3009343) pH of Capillary blood
207
1429
1.54
6.29
22.4
9.6
ph
7.4
7.4
2.72
13
51
(3022313) Gas panel - Capillary blood
185
1252
1.55
6.13
22.0
9.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
234
2.18
6.08
13.5
10.8
iu/ml
806.9
350.0
—
8
35
(3028626) Oxygen [Partial pressure] in Capillary blood
189
1316
1.51
5.44
21.8
9.5
kpa
9.5
9.7
0.67
182
1271
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
196
2.19
5.24
2.0
2.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
209
2.15
5.24
15.9
12.3
u/ml
81.2
296.2
1.49
11
25
(3012095) Magnesium [Moles/volume] in Serum or Plasma
134
872
1.58
5.23
16.4
13.4
mmol/l
0.8
0.8
0.48
128
842
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
252
2.02
5.06
2.5
2.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
51
254
2.01
4.96
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
51
254
2.01
4.96
1.8
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
135
891
1.56
4.95
5.0
3.1
umol/l
13.6
14.0
0.16
128
859
(40767503) Oxygen content in Capillary blood by calculation
29
115
2.50
4.84
3.4
3.4
%
17.8
17.8
0.03
21
71
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
197
2.12
4.79
1.9
2.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
8
7
11.17
4.70
8.6
1.3
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
10
20
4.89
4.58
1.1
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
88
534
1.67
4.55
13.3
8.3
ng/l
51.2
51.4
0.02
88
522
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
343
2735
1.36
4.52
23.9
13.0
mmol/l
1.2
1.2
0.33
328
2617
(3020393) Adenovirus Ag [Presence] in Stool
33
146
2.24
4.36
2.3
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
126
846
1.52
4.26
21.8
14.2
mmol/l
5.7
5.1
1.15
121
833
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
354
2859
1.35
4.21
23.3
12.0
mmol/l
1.2
1.2
0.05
326
2652
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
136
935
1.49
4.11
2.5
5.1
mg/l
1.8
1.8
0.04
88
633
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
251
1.91
4.10
2.4
2.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
121
813
1.52
4.08
1.6
1.5
u/ml
167.5
359.4
2.05
109
771
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
7
7
9.76
3.93
1.9
3.7
—
—
—
0
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
15
47
3.13
3.85
2.0
1.9
mg/l
2.5
1.4
0.26
15
40
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
15
47
3.13
3.85
2.0
1.9
mg/l
2.1
6.5
2.36
15
37
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
15
47
3.13
3.85
2.0
1.9
mg/l
0.8
1.3
1.09
15
42
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
15
47
3.13
3.85
2.0
1.9
mg/l
2.9
3.8
—
10
37
(3022670) pH of Venous cord blood
17
58
2.88
3.80
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
62
361
1.72
3.76
1.7
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
45
239
1.87
3.69
16.6
9.8
mmol/l
23.1
22.9
0.17
45
223
(3015377) Calcium [Moles/volume] in Serum or Plasma
182
1354
1.39
3.57
4.0
2.8
mmol/l
2.4
2.4
0.12
173
1236
(3021901) Oxygen saturation in Capillary blood
30
141
2.10
3.47
8.3
7.5
—
—
—
0
0
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
6
6
9.75
3.43
7.2
5.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
104
703
1.50
3.41
1.5
1.4
nmol/l
20.4
18.7
0.54
87
633
(40758558) Short blood count panel - Blood
270
2149
1.32
3.39
8.6
9.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
141
1013
1.42
3.38
3.9
4.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
29
136
2.10
3.37
5.5
5.6
ug/l
2.5
2.3
0.18
29
136
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
22
92
2.35
3.35
4.2
5.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
252
1990
1.32
3.33
8.0
8.4
umol/l
32.9
22.3
2.17
231
1819
(40757494) Bilirubin.total [Moles/volume] in Blood
16
57
2.75
3.33
10.4
3.2
umol/l
130.0
158.6
0.59
11
27
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
10
6.83
3.29
1.4
3.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
165
1.98
3.25
1.9
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
61
371
1.64
3.18
9.5
8.2
g/l
0.5
0.5
0.09
48
297
(3018677) aPTT in Platelet poor plasma by Coagulation assay
134
965
1.41
3.16
3.6
7.3
s
31.4
31.4
0.05
134
955
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
114
801
1.44
3.08
2.6
2.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
98
670
1.47
3.05
23.4
19.9
mg/l
1.1
1.0
1.70
98
659
(3000991) Gas panel - Venous blood
169
1276
1.36
3.00
14.1
11.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
110
2.15
2.98
1.6
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
372
3132
1.27
2.94
10.7
7.4
mmol/l
5.9
5.9
0.00
350
2934
(3018418) pH of Serum or Plasma
155
1159
1.36
2.92
5.9
3.9
ph
7.4
7.4
0.23
32
195
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
186
1.86
2.91
1.9
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
78
514
1.52
2.91
10.9
12.3
mmol/l
106.2
105.7
0.50
78
509
(44790048)
37
204
1.79
2.76
2.8
2.1
—
—
—
0
0
(44790047)
37
204
1.79
2.76
2.8
2.1
—
—
—
0
0
(44790049)
37
204
1.79
2.76
2.8
2.1
—
—
—
0
0
(44806118)
37
204
1.79
2.76
2.8
2.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
24
114
2.07
2.74
3.4
2.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
73
481
1.52
2.74
3.2
8.6
g/l
2.8
2.7
0.09
67
474
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
52
2.64
2.73
1.9
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
188
2233
0.76
2.72
2.4
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
88
606
1.46
2.66
2.6
2.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
47
2.71
2.66
2.2
1.5
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
31
3.15
2.63
1.4
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
384
3275
1.25
2.63
7.6
5.6
u/l
141.1
119.4
3.38
371
3078
(3017181) Myelocytes/100 leukocytes in Blood
61
390
1.56
2.62
6.7
5.7
%
1.2
0.5
0.71
25
119
(3042936) Bacteria identified in Isolate by Culture
84
578
1.45
2.56
1.9
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
111
2.04
2.54
4.3
5.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
88
612
1.44
2.54
2.8
2.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
170
1316
1.32
2.53
10.7
9.9
mmol/l
23.7
23.6
0.25
164
1285
(3051651) Icteric interference index of Serum or Plasma
21
98
2.10
2.52
4.3
5.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
139
1.91
2.50
9.6
5.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
57
364
1.56
2.48
6.7
5.8
%
0.0
0.0
0.00
22
99
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
72
484
1.48
2.47
2.9
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
47
288
1.62
2.43
1.9
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
71
478
1.48
2.42
2.9
1.9
u/ml
206.8
163.1
0.39
34
222
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
70
472
1.48
2.37
1.5
1.4
pmol/l
547.7
15952827.2
0.50
62
420
(3052851) Hemolysis interference index of Serum or Plasma
36
208
1.71
2.33
3.8
4.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
56
363
1.53
2.29
6.2
5.1
%
0.7
0.3
0.44
20
83
(3023520) Reticulocytes [#/volume] in Blood
86
608
1.41
2.28
3.7
5.3
e9/l
66.1
64.5
0.09
66
370
(3000850) Epithelial cells [#/volume] in Urine
165
1291
1.30
2.27
6.1
3.6
e6/l
6.6
6.8
0.06
137
1138
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
195
1.72
2.26
1.2
2.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
271
1.61
2.24
2.8
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
683
6275
1.30
2.24
12.2
7.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
408
3551
1.22
2.18
10.7
11.0
e9/l
0.0
0.0
0.80
334
2735
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
35
2.79
2.18
1.9
4.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
178
1414
1.28
2.18
14.0
10.3
mmol/l
1.0
1.1
0.11
145
1116
(3042733) HLA Ab [Presence] in Serum
15
65
2.26
2.17
3.3
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
248
2052
1.24
2.14
4.5
4.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
181
2104
0.79
2.14
2.3
2.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
22
112
1.93
2.13
10.6
7.5
mmol/l
1.5
1.5
0.07
12
53
(3012544) pH of Venous blood
178
1418
1.27
2.13
14.7
10.4
—
7.4
—
0
8
(42870588) Differential panel, method unspecified - Blood
338
2892
1.22
2.12
8.9
10.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
56
371
1.50
2.09
7.1
5.8
%
0.1
0.1
0.32
24
111
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
25
134
1.83
2.09
6.7
6.6
u/ml
69.4
17.7
0.68
25
126
(4035726)
46
292
1.56
2.09
1.6
1.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
171
1365
1.27
2.01
13.0
10.2
kpa
5.2
5.1
0.11
165
1338
(3007853) Bacteria identified in Skin by Aerobe culture
107
802
1.34
2.01
2.2
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
22
115
1.88
1.99
1.0
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
177
1421
1.26
1.98
14.1
10.3
kpa
5.7
5.8
1.28
172
1387
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
15
3.90
1.98
1.0
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
97
719
1.35
1.96
7.7
7.9
umol/l
6.0
6.2
0.10
83
598
(3020891) Body temperature
21
109
1.89
1.94
9.6
7.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
26
3.00
1.94
1.6
6.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
119
1441
0.77
1.94
2.0
2.3
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
5
11
4.42
1.89
3.8
3.9
umol/l
0.4
0.5
—
5
11
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
16
3.65
1.88
1.0
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
42
269
1.54
1.86
6.1
7.2
ng/l
203.5
226.5
0.10
35
246
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
77
2.03
1.83
16.7
8.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
51
342
1.47
1.83
3.8
2.2
u/ml
72.5
82.0
—
5
20
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
275
2337
1.21
1.80
5.6
3.4
nmol/l
69.8
67.1
0.90
261
2220
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
101
1236
0.76
1.78
1.8
2.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
109
834
1.31
1.78
3.5
2.7
nmol/l
320.4
349.5
0.78
104
800
(3000012) Reticulocyte production index
6
17
3.44
1.78
3.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
17
3.44
1.78
1.0
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
158
1270
1.25
1.75
5.3
3.4
mosm/kgh2o
555.1
603.0
1.34
130
1110
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
65
2.11
1.75
1.5
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
123
959
1.28
1.75
2.5
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
437
3884
1.19
1.72
9.8
10.1
e9/l
0.2
0.2
1.27
387
3311
(3014111) Lactate [Moles/volume] in Serum or Plasma
83
614
1.34
1.72
12.3
14.7
mmol/l
1.2
1.4
0.95
78
551
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
166
1.66
1.70
2.8
1.9
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
18
3.25
1.69
2.2
1.6
nmol/l
236.8
149.9
—
6
18
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
53
2.21
1.69
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
238
2007
1.21
1.67
7.1
4.4
e6/l
254.8
34.5
0.48
187
1498
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
38
245
1.53
1.65
8.2
5.8
mmol/l
1.2
1.2
0.13
33
216
(3019069) Monocytes/100 leukocytes in Blood
416
3692
1.18
1.64
9.5
9.6
%
8.3
8.2
0.05
392
3543
(3009214) Lutropin [Units/volume] in Serum or Plasma
76
561
1.34
1.61
2.4
2.2
u/l
5.9
6.0
0.04
57
361
(3004616) Nuclear Ab [Presence] in Serum
7
25
2.73
1.59
1.7
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
412
3663
1.18
1.57
9.2
9.5
%
2.8
3.2
3.29
393
3516
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
29
178
1.60
1.56
1.7
1.4
umol/l
5.3
5.0
0.23
29
160
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
29
178
1.60
1.56
14.9
8.1
%
56.2
57.2
0.08
29
173
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
41
0.00
1.53
0.0
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
423
3776
1.17
1.51
9.3
9.3
e9/l
0.0
0.0
0.06
364
3161
(3030467) Casts [#/volume] in Urine by Automated count
221
1871
1.20
1.48
6.6
4.3
e6/l
0.5
0.2
0.38
170
1372
(3023323) Follitropin [Units/volume] in Serum or Plasma
66
484
1.35
1.47
2.5
2.2
iu/l
8.7
6.9
0.46
50
316
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
113
1.73
1.47
1.8
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
79
971
0.77
1.46
1.5
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
597
5491
1.19
1.45
20.2
12.2
mmol/l
4.0
3.9
3.12
581
5308
(3022096) Basophils/100 leukocytes in Blood
400
3564
1.17
1.44
9.2
9.7
%
0.6
0.6
0.35
383
3424
(3017446) Testosterone [Moles/volume] in Serum or Plasma
61
444
1.36
1.43
2.0
2.2
nmol/l
8.9
8.7
0.05
54
345
(3003396) Base excess in Arterial blood by calculation
46
319
1.42
1.43
10.7
14.1
mmol/l
-0.5
-0.3
0.11
36
246
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
372
0.64
1.40
1.2
1.1
u/ml
5.7
10.4
0.77
14
223
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
145
1.62
1.40
1.8
1.3
ug/g
342.9
384.3
0.47
16
69
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
247
2123
1.18
1.38
7.7
4.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
39
264
1.45
1.38
1.4
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
147
1205
1.22
1.37
5.5
4.3
inr
1.0
1.1
1.06
48
350
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
40
2.19
1.36
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
45
594
0.72
1.35
1.2
1.2
u/ml
5.2
4.0
0.12
15
207
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
142
1162
1.22
1.35
1.8
1.5
pmol/l
103.6
98.1
0.54
64
626
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
36
0.00
1.35
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
35
234
1.47
1.33
6.3
4.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
421
3783
1.16
1.32
9.0
9.1
%
47.8
49.1
1.16
400
3644
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
41
2.14
1.32
1.4
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
41
2.14
1.32
1.4
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
41
2.14
1.32
1.4
1.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
596
5499
1.17
1.32
20.2
12.2
mmol/l
139.4
139.4
0.10
583
5340
(3001604) Monocytes [#/volume] in Blood
420
3775
1.16
1.31
9.4
9.3
e9/l
0.6
0.6
2.06
361
3159
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
40
0.00
1.31
0.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
49
350
1.38
1.31
4.0
2.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
428
3856
1.15
1.29
9.1
9.3
%
36.8
35.6
1.14
406
3703
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
46
597
0.73
1.26
1.2
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
24
2.43
1.25
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
35
2.23
1.24
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
52
658
0.75
1.21
1.2
1.2
u/ml
3.0
3.0
0.00
36
418
(3008898) HLA-B27 [Presence]
21
313
0.64
1.21
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
297
1.39
1.20
2.2
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
147
1222
1.20
1.20
5.3
3.8
e6/l
2.9
3.3
0.16
94
693
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
37
2.11
1.18
1.1
1.9
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
34
0.00
1.15
0.0
2.0
—
1.7
—
0
25
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
23
332
0.66
1.15
1.1
1.1
u/ml
2.1
0.4
0.37
12
145
(3013650) Neutrophils [#/volume] in Blood by Automated count
449
4080
1.14
1.15
11.7
10.9
e9/l
3.4
3.5
0.07
382
3401
(3028300) Cannabinoids [Presence] in Urine
84
992
0.80
1.15
1.5
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
83
981
0.80
1.14
1.5
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
110
1262
0.82
1.14
1.7
1.8
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
35
0.00
1.14
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
33
444
0.71
1.14
1.5
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
16
92
1.70
1.14
7.2
11.4
mg/l
10.3
9.2
0.30
16
86
(3018095) Leukocytes [#/volume] in Urine
266
2334
1.15
1.13
8.4
5.2
e6/l
47.2
60.6
0.30
191
1564
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
143
1194
1.19
1.12
5.1
3.7
e6/l
0.9
1.0
0.14
89
664
(3027008) Opiates [Presence] in Urine
84
989
0.80
1.12
1.5
1.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
39
2.00
1.11
20.1
11.7
nmol/l
668.8
699.5
—
8
39
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
20
2.43
1.11
2.4
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
77
912
0.80
1.09
1.5
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
12
64
1.83
1.08
2.1
2.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
67
518
1.28
1.08
6.2
7.6
ng/l
1813.7
1152.0
0.55
59
430
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
40
1.95
1.08
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
152
1281
1.18
1.08
4.6
2.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
164
1.49
1.07
2.2
2.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
121
1366
0.83
1.06
3.6
3.3
ug/g
75.9
112.9
1.76
98
1067
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
120
0.48
1.06
1.0
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
42
305
1.35
1.05
1.5
1.6
nmol/l
1433.0
1018.5
1.95
33
238
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
256
0.64
1.05
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
16
95
1.64
1.03
5.4
3.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
33
2.06
1.02
1.4
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
15
88
1.66
1.01
2.9
2.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
428
3899
1.13
1.01
9.3
9.2
e9/l
2.5
2.4
1.40
376
3364
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
63
756
0.79
1.01
1.2
1.2
—
50.0
—
0
8
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
143
1.50
0.99
2.5
2.9
—
774.5
—
0
13
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
36
465
0.74
0.99
1.4
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
104
1.60
0.99
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
169
0.57
0.98
1.9
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
21
297
0.68
0.98
1.1
1.1
u/ml
5.0
8.2
—
5
35
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.2
—
5.1
—
0
23
(3009466) Valproate [Moles/volume] in Serum or Plasma
23
152
1.48
0.97
5.8
4.5
umol/l
432.8
436.6
0.03
23
144
(1001926) Buprenorphine [Presence] in Urine by Screen method
66
783
0.80
0.96
1.5
2.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
50
613
0.78
0.96
1.1
1.2
u/ml
5.5
6.0
0.10
36
446
(36304419) Bacteria [Presence] in Urine
217
1898
1.15
0.96
6.6
4.2
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
0
31
0.00
0.95
0.0
1.5
—
2.1
—
0
26
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
238
0.64
0.95
1.7
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
31
406
0.73
0.94
1.1
1.1
u/ml
9.6
6.8
0.18
15
227
(3008401) Mugwort IgE Ab [Units/volume] in Serum
49
599
0.78
0.92
1.1
1.2
u/ml
0.4
1.1
2.09
32
413
(3026008) Bacteria identified in Urine by Culture
168
1450
1.15
0.89
3.9
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
55
427
1.27
0.89
5.5
3.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
54
1.80
0.89
1.1
1.3
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
15
92
1.59
0.87
2.3
4.1
%
3.6
4.3
—
5
34
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
42
1.85
0.87
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
23
311
0.71
0.86
1.2
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
351
3183
1.12
0.86
4.0
3.2
ug/l
51.4
55.2
0.18
335
3026
(40768797) Stomach Pathology biopsy report
49
378
1.27
0.84
1.8
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
101
1.55
0.84
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
196
0.64
0.84
1.9
1.7
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
207
0.65
0.83
1.1
1.3
u/ml
1.9
20.5
—
9
166
(3011288) Drugs identified in Urine by Screen method
57
673
0.81
0.82
1.7
2.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
71
1.65
0.80
1.2
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
23
0.00
0.79
0.0
1.1
—
—
—
0
0
(4306422)
14
87
1.57
0.79
1.0
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
27
0.00
0.76
0.0
3.3
—
0.3
—
0
27
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
185
1626
1.13
0.76
3.7
3.2
mg/l
2.9
2.7
0.70
168
1460
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
224
0.69
0.74
1.9
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
81
1.56
0.73
2.0
1.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
54
1.62
0.73
12.9
10.5
mmol/l
1.3
1.2
—
9
47
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
89
1.53
0.73
1.4
1.3
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
48
379
1.24
0.70
1.0
1.0
mu/l
9.5
8.7
0.32
43
329
(40761535) Cells panel - Urine sediment
34
257
1.29
0.70
6.4
3.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
9
56
1.56
0.70
2.6
2.0
ug/l
1.0
0.8
—
9
47
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
147
1.39
0.70
2.4
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
223
1995
1.11
0.69
1.6
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
123
1.43
0.68
1.7
1.8
iu/l
2.7
4.9
—
8
45
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
41
1.66
0.68
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
41
1.66
0.68
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
643
6067
1.12
0.67
19.8
14.9
%
13.3
13.1
1.94
627
5949
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
286
1.27
0.66
3.0
2.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
10
60
1.62
0.65
19.8
10.7
mmol/l
1.2
1.2
—
10
55
(3014051) Protein [Presence] in Urine by Test strip
8
125
0.62
0.64
1.4
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
126
0.61
0.64
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
28
1.73
0.64
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
281
2556
1.10
0.62
7.3
4.9
estimate
0.0
0.0
0.00
52
464
(36660697) Celiac disease serology panel - Serum
110
1193
0.88
0.62
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
282
2567
1.10
0.62
5.3
3.3
estimate
0.0
0.0
0.00
47
437
(3030313) Adrenal Ab [Titer] in Serum
5
29
1.67
0.61
2.8
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
49
1.59
0.61
1.4
1.5
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
49
1.59
0.61
1.4
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
49
1.59
0.61
1.4
1.5
—
—
—
0
0
(40763527) Lymphocytes.vacuolated [Presence] in Blood by Light microscopy
0
19
0.00
0.60
0.0
1.1
—
0.0
—
0
11
(3008536) Aspergillus sp Ab [Presence] in Serum
0
19
0.00
0.60
0.0
2.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
19
0.00
0.60
0.0
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
20
0.00
0.60
0.0
3.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
20
0.00
0.60
0.0
3.4
—
13.7
—
0
20
(3021706) Oxygen [Partial pressure] in Arterial cord blood
37
290
1.25
0.60
1.0
1.0
kpa
3.0
3.3
0.64
31
244
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
203
1.30
0.60
1.3
1.2
—
—
—
0
0
(4062490)
19
135
1.37
0.60
1.8
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
25
186
1.31
0.59
10.3
19.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
235
0.74
0.59
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
78
1.50
0.58
1.2
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
161
1429
1.11
0.58
5.9
4.7
mmol/l
8.2
8.7
0.42
152
1352
(3004588) Protein electrophoresis panel - Serum or Plasma
8
52
1.50
0.57
1.1
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
35
1.67
0.56
1.5
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
95
1.44
0.56
1.3
1.3
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
37
293
1.23
0.56
1.0
1.0
mmol/l
-1.2
-2.5
—
10
68
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
37
293
1.23
0.56
1.0
1.0
kpa
7.4
7.2
0.15
31
247
(3006598) pH of Arterial cord blood
37
293
1.23
0.56
1.0
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
148
1311
1.11
0.56
7.5
5.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
20
146
1.34
0.54
2.1
4.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
58
1.51
0.54
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
59
1.48
0.54
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
138
1.34
0.54
4.8
4.5
%
51.8
51.2
0.07
19
138
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
176
1577
1.10
0.53
3.8
5.2
u/l
34.3
34.1
0.02
170
1515
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
30
233
1.26
0.53
13.6
18.0
%
0.7
0.8
0.15
30
233
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
38
304
1.22
0.53
1.1
1.3
miu/ml
266.8
225.1
0.33
19
131
(3023410) Appearance of Cerebral spinal fluid
15
197
0.73
0.52
1.9
5.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
73
803
0.87
0.52
1.7
1.6
titre
564.7
529.5
0.04
17
130
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
96
0.60
0.52
1.3
3.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
96
0.60
0.52
1.3
3.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
35
410
0.82
0.51
1.6
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
18
229
0.76
0.51
1.4
1.2
—
—
—
0
0
(3013512) EKG study
79
677
1.14
0.51
2.7
2.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
522
1.16
0.51
1.5
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
548
5167
1.08
0.48
4.2
3.7
mu/l
2.1
2.0
0.93
512
4875
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
583
0.86
0.48
1.2
1.2
u/ml
2.5
8.1
1.10
17
162
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
45
1.51
0.48
1.0
1.2
—
55.7
—
0
10
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
193
1.26
0.48
4.9
3.2
ml/min/173m2
80.4
91.7
—
9
56
(3029937) Albumin [Presence] in Urine by Test strip
143
1277
1.10
0.47
6.3
3.4
estimate
0.0
0.0
0.00
48
435
(3024731) MCV [Entitic volume]
759
7264
1.13
0.47
20.5
15.2
fl
85.9
86.0
0.20
745
7143
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
46
1.48
0.47
1.0
1.2
—
82.0
—
0
10
(3028707) Methadone [Presence] in Urine by Screen method
39
447
0.84
0.47
1.7
2.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
99
1.38
0.47
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
159
1.29
0.46
1.3
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
47
1.45
0.46
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
279
2569
1.08
0.46
5.4
3.4
estimate
0.0
0.0
0.00
53
455
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
81
0.60
0.46
1.0
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
759
7267
1.13
0.45
20.5
15.2
pg
28.9
28.9
0.02
745
7148
(3026361) Erythrocytes [#/volume] in Blood
759
7268
1.13
0.44
20.5
15.2
e12/l
4.7
4.6
1.35
729
6884
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
43
356
1.18
0.44
2.2
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
152
1.28
0.44
1.8
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
760
7280
1.13
0.43
20.6
15.2
e9/l
7.0
7.0
0.12
730
6902
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
135
1.30
0.43
4.7
4.0
e9/l
3.5
3.4
0.11
18
135
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
280
2844
0.93
0.43
1.7
1.8
u/ml
4.0
3.4
0.12
56
525
(3015076) Soybean IgE Ab [Units/volume] in Serum
15
190
0.76
0.43
1.3
1.2
u/ml
1.0
1.1
—
6
55
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
16
118
1.32
0.43
1.4
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
111
985
1.11
0.42
1.5
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
603
5720
1.08
0.42
10.1
8.7
u/l
27.0
25.1
0.72
584
5527
(3042517) Benzodiazepines panel - Urine
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
89
782
1.12
0.41
2.6
2.2
ng/l
12.0
57.1
2.15
45
241
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
7.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
16
119
1.31
0.41
1.4
1.2
%
61.8
78.1
1.15
16
119
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
130
1166
1.10
0.41
3.2
2.9
u/l
56.6
55.6
0.06
125
1084
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
102
1.34
0.40
1.1
1.3
u/ml
10.2
3.0
—
6
60
(3000963) Hemoglobin [Mass/volume] in Blood
759
7274
1.12
0.40
20.8
15.6
g/l
134.3
133.1
1.48
746
7159
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
337
3394
0.94
0.40
2.0
2.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
209
0.78
0.40
1.1
1.3
mg/l
8.3
4.2
0.53
11
132
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
18
0.00
0.39
0.0
1.6
—
55.8
—
0
18
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
34
1.43
0.39
3.2
3.1
—
—
—
0
0
(3015736) pH of Urine
225
2069
1.07
0.39
4.9
3.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
55
471
1.14
0.38
3.7
4.1
mg/l
142.6
263.0
0.37
48
391
(3003740) Influenza virus B Ag [Presence] in Specimen
29
235
1.20
0.38
1.4
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
35
1.39
0.38
1.0
1.1
nmol/l
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
35
1.39
0.38
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
200
1.22
0.37
1.4
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
228
0.80
0.37
1.2
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
29
236
1.20
0.37
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
238
0.81
0.37
1.8
1.5
iu/ml
0.0
0.0
—
5
64
(3000330) Specific gravity of Urine by Test strip
15
185
0.78
0.37
2.7
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
57
619
0.88
0.37
1.2
1.2
iu/ml
11.3
25.8
0.81
11
125
(3007461) Platelets [#/volume] in Blood
757
7260
1.11
0.36
20.6
15.3
e9/l
276.6
272.2
0.95
729
6898
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
174
0.78
0.36
1.2
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
321
0.84
0.36
1.1
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
40
1.46
0.36
1.3
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
40
1.46
0.36
1.3
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
6
41
1.42
0.35
1.0
1.1
ng/l
—
78.5
—
0
8
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
6
41
1.42
0.35
1.2
1.0
—
19.6
—
0
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
505
0.88
0.35
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
13
162
0.77
0.35
1.5
1.2
—
0.2
—
0
9
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
43
1.35
0.34
3.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
167
1.22
0.34
2.5
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
199
2026
0.94
0.33
2.1
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
193
1780
1.07
0.31
5.3
3.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
19
151
1.22
0.31
11.9
7.0
inr
1.0
1.2
—
5
30
(1761868) Lipid panel - Serum or Plasma
110
994
1.08
0.31
2.0
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
95
0.71
0.31
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
81
1.32
0.31
3.1
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
358
3573
0.95
0.30
6.8
3.8
e6/l
538.2
226.7
0.25
12
47
(3000492) Spirometry study
39
427
0.88
0.30
1.7
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
13
158
0.79
0.29
1.9
2.3
—
64.8
—
0
21
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
321
3209
0.95
0.29
3.4
2.5
mmol/l
1.3
1.4
2.61
300
3024
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
91
1.28
0.28
1.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
61
1.27
0.28
2.8
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
43
373
1.12
0.27
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
65
1.19
0.26
1.6
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
357
3368
1.05
0.26
8.1
6.0
ml/min/173m2
115.7
114.8
0.30
226
2154
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
110
1.24
0.26
2.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
182
1.18
0.25
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
146
1.20
0.25
1.2
1.3
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
10
123
0.79
0.25
1.1
1.3
u/ml
4.6
7.0
—
10
107
(3003338) MCHC [Mass/volume]
659
6310
1.06
0.25
17.9
14.2
g/l
335.7
334.9
1.23
651
6237
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
99
901
1.07
0.25
1.7
1.8
mmol/l
1.3
1.2
0.54
92
833
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
332
3305
0.96
0.24
3.6
2.7
mmol/l
4.2
4.3
0.42
312
3135
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17
138
1.20
0.24
1.4
1.2
—
44.8
—
0
5
(40768804) Tissue Pathology biopsy report
127
1168
1.06
0.24
1.7
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
174
0.83
0.23
1.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
85
1.26
0.23
1.4
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
36
313
1.12
0.23
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
325
3231
0.96
0.22
3.4
2.5
mmol/l
2.6
2.6
0.18
304
3024
(3045142) Bone marrow Pathology biopsy report
7
92
0.74
0.22
1.7
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
13
152
0.83
0.22
1.8
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
185
1.16
0.22
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
231
1.14
0.22
1.3
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(4281824)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.9
—
2.3
—
0
11
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
703
6871
0.95
0.21
4.1
3.9
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
192
0.86
0.21
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
69
715
0.93
0.21
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
161
0.84
0.20
1.5
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
177
1.15
0.20
1.2
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.20
0.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
13
0.00
0.20
0.0
2.2
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
13
0.00
0.20
0.0
3.8
—
12.8
—
0
7
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
157
1461
1.05
0.20
4.9
3.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
46
1.27
0.20
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
55
494
1.08
0.20
1.5
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
14
0.00
0.20
0.0
4.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
49
1.19
0.19
19.2
3.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
324
3069
1.04
0.19
3.4
2.5
mmol/l
1.2
1.1
1.23
311
2910
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
660
6337
1.04
0.18
15.1
10.6
mg/l
20.8
23.1
1.03
479
4270
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
115
1.18
0.18
2.3
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
97
1.20
0.18
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
235
1.12
0.18
5.8
5.4
umol/l
18.1
12.1
0.65
27
203
(3037467) Urinalysis macro (dipstick) panel - Urine
386
3673
1.03
0.17
6.3
4.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
280
0.90
0.17
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
290
0.90
0.17
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
134
1350
0.95
0.17
1.7
1.7
—
—
—
0
0
(4010399)
35
310
1.10
0.17
1.6
1.4
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
5
67
0.72
0.17
1.2
1.0
—
9.5
—
0
7
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
67
0.72
0.17
1.2
1.6
umol/l
12.5
8.7
—
5
67
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
107
1.18
0.16
1.2
1.3
u/ml
10.0
3.9
—
7
54
(3044889) 12 lead EKG panel
241
2277
1.04
0.16
2.7
2.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
8
67
1.16
0.16
1.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
68
1.14
0.16
3.5
1.7
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
8
69
1.12
0.16
2.1
2.7
—
274.3
—
0
19
(4268621)
8
70
1.11
0.16
2.0
2.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
298
0.91
0.16
1.1
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
78
0.74
0.15
6.7
5.3
—
98.1
—
0
9
(21494434) Karyotype in Bone marrow
6
78
0.74
0.15
1.8
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
78
1.12
0.15
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
347
0.92
0.15
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
79
1.11
0.15
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
145
1.14
0.15
2.2
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
62
568
1.06
0.15
1.4
1.3
iu/ml
276.3
152.5
0.79
19
181
(4034850)
9
80
1.09
0.14
8.6
5.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
411
3924
1.03
0.14
5.4
4.2
mm/h
6.9
7.2
0.32
386
3636
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
86
0.79
0.14
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
684
6582
1.04
0.14
16.9
14.0
%
39.5
39.3
0.64
610
5849
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
19
205
0.90
0.13
1.5
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
154
0.88
0.13
1.1
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
157
1.11
0.12
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
204
1.10
0.11
3.1
3.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
24
252
0.92
0.11
1.7
4.2
mmol/l
3.1
3.3
0.38
24
242
(40765089) Chromosome analysis panel - Blood by G-banded
12
102
1.14
0.10
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
52
480
1.05
0.10
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
80
748
1.04
0.10
3.1
2.3
u/l
11516.6
6286.3
0.49
21
202
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
43
1.13
0.10
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
43
1.13
0.10
1.6
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
43
1.13
0.10
1.6
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
43
1.13
0.10
1.6
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
206
1.08
0.09
11.4
18.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
44
1.10
0.09
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
45
1.08
0.09
1.6
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
45
1.08
0.09
3.2
2.8
mmol/l
3.6
3.9
—
5
39
(1002224) Polysomnography panel
5
45
1.08
0.09
1.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
45
1.08
0.09
1.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
46
1.05
0.09
3.2
2.7
umol/l
21.5
18.8
—
5
46
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
46
1.05
0.09
1.2
1.2
iu/ml
207.2
252.8
—
5
46
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
46
1.05
0.09
1.6
2.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
61
568
1.04
0.09
2.0
2.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
47
1.03
0.09
19.2
3.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
52
1.12
0.09
2.2
3.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
53
1.10
0.09
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
270
2652
0.98
0.08
1.8
1.7
g/l
1.5
1.5
0.11
143
1397
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
57
1.02
0.08
1.0
1.1
mg/l
247.0
281.9
—
6
57
(3045424) Erythrocytes [Presence] in Urine
5
60
0.81
0.08
2.8
1.6
—
—
—
0
0
(3049233) Organic acids panel - Urine
5
62
0.78
0.08
1.0
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
288
2825
0.98
0.08
4.6
4.4
u/l
29.3
24.9
1.14
274
2719
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
657
1.04
0.07
3.3
3.9
ng/l
1905.2
1346.6
0.21
35
358
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
68
0.85
0.07
2.3
2.9
u/ml
7.0
49.0
—
6
59
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.05
0.07
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
74
1.05
0.07
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
514
1.04
0.07
1.4
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
75
1.03
0.07
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
75
1.03
0.07
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
75
1.03
0.07
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
75
1.03
0.07
1.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
298
2856
1.02
0.07
3.8
2.9
mmol/mol
35.4
35.8
0.22
277
2694
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
86
1.13
0.07
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
83
1.05
0.07
1.4
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
86
1.01
0.07
1.1
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
88
0.88
0.07
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
38
384
0.96
0.06
1.6
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
98
0.89
0.06
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
101
0.86
0.06
1.7
1.5
u/l
6.0
7.4
—
9
90
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
210
2009
1.02
0.06
1.7
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
483
4654
1.01
0.05
3.7
3.3
pmol/l
14.5
14.4
0.55
436
4149
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
176
0.93
0.05
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
176
0.93
0.05
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
176
0.93
0.05
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
176
0.93
0.05
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
358
3494
0.99
0.05
2.6
2.1
mmol/l
5.4
5.3
0.63
318
3209
(3017732) Neutrophils [#/volume] in Blood
38
356
1.04
0.04
2.0
1.8
e9/l
3.9
4.3
0.42
32
327
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
155
1.06
0.04
1.6
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
28
261
1.04
0.03
1.7
4.2
mg/l
401.2
399.5
0.01
28
256
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
86
844
0.99
0.02
1.8
1.5
%
1.4
1.3
0.39
81
772
(3019150) Specific gravity of Urine by Refractometry
133
1300
0.99
0.02
5.1
2.8
kg/l
1.0
1.0
0.94
26
239
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
119
1.06
0.02
1.1
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
22
206
1.04
0.01
3.0
3.2
e6/l
751.5
532.2
0.97
22
141
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
29
274
1.03
0.01
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
32
303
1.02
0.01
1.6
1.6
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
11
113
0.94
0.01
1.1
1.3
u/ml
2.6
16.4
2.25
11
101
(40768443) Skin Pathology biopsy report
14
142
0.95
0.01
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
132
0.95
0.01
1.6
1.5
—
—
—
0
0
(4198724)
14
130
1.04
0.00
1.6
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
129
0.98
0.00
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
129
0.98
0.00
1.5
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
22
208
1.03
0.00
3.0
3.2
e9/l
0.2
0.2
0.36
22
142
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
14
131
1.04
0.00
2.8
2.5
mmol/l
1.2
2.1
—
9
105
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
127
0.99
0.00
2.7
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
22
210
1.02
0.00
3.1
3.3
%
8.9
9.4
0.12
22
192
(3011412) CD3 cells [#/volume] in Blood
22
217
0.98
0.00
3.0
3.3
e9/l
2.1
1.4
1.09
22
141
(3011648) Oxygen content in Venous blood
14
133
1.02
0.00
10.6
24.9
%
12.3
11.3
0.58
14
133
(3016018) Differential panel - Cerebral spinal fluid
16
160
0.97
0.00
1.4
4.0
—
—
—
0
0
(44813793)
14
134
1.01
0.00
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
119
0.98
0.00
2.6
2.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
175
1.00
0.00
1.7
2.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
18
175
1.00
0.00
1.5
1.6
ug/l
10.9
6.1
0.41
18
160
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
26
250
1.01
0.00
1.8
4.4
e6/l
47.6
10.8
0.42
20
180
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
93
902
1.00
0.00
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
301
1.00
0.00
7.2
2.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
25
241
1.01
0.00
1.7
4.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
29
282
1.00
0.00
1.5
2.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
12
121
0.96
0.00
1.0
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
8
84
0.92
0.00
1.1
1.1
mg/l
191.3
202.1
—
8
78
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
84
0.92
0.00
1.1
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
58
0.83
0.00
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
80
0.97
0.00
1.1
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
80
0.97
0.00
1.5
1.1
—
—
—
0
0
(40760083) Phosphate/Creatinine [Ratio] in Urine
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
24.2
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
51.8
—
0
8
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
35.6
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
67
1.01
0.00
1.3
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
58
1.00
0.00
1.0
3.2
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
20.0
—
0
6
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
58
1.00
0.00
1.0
1.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
49
0.99
0.00
1.4
1.1
—
—
—
0
0
(3017894) Mustard IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
53.7
—
0
5
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
243.4
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
74
0.92
0.00
1.6
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
20.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(4027681)
7
77
0.88
0.00
1.6
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
95
0.92
0.00
2.2
1.6
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
1118.6
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
7
0.00
0.00
0.0
1.1
—
37.8
—
0
7
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
49
0.99
0.00
1.2
1.1
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED | 3.516 [2.95, 4.19] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.206 |
During the follow-up period (1.1.1998 — 31.12.2019), 183 out of 21756 females with P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED | 2.27 [1.96, 2.63] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 236 out of 25440 males with P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED died.
Mortality risk
Mortality risk for people of age
years, who have P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.389% | 0.476% |
| 5 | 2.249% | 2.702% |
| 10 | 5.077% | 6.732% |
| 15 | 10.073% | 12.848% |
| 20 | 16.689% | 20.649% |
Relationships between endpoints
↥Index endpoint: P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED – Disorders related to short gestation and low birth weight, not elsewhere classified
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data